Dr. Steven Pipe on HEMGENIX, hemophilia B’s first gene therapy
BloodStream
English - January 27, 2023 08:00 - 44 minutes - 64.4 MB - ★★★★★ - 38 ratingsAlternative Health Health & Fitness advocacy biotech bleedingdisorders haemophilia healthcare hematology hemofilia hemophilia inhibitors insurance Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Previous Episode: Legislative wins and losses & CDC’s Aditi Kantipuly
We’ve got Dr. Steven Pipe with us to discuss the first gene therapy approved for hemophilia B, HEMGENIX. As the lead investigator of the HEMGENIX trial, Dr. Pipe details what patients need to know about HEMGENIX and what questions to consider when speaking with their hematologist. A must listen episode!
Show Notes:
Subscribe:
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
Connect with BloodStream Media: